Prenetics Global Limited (PRE)
After hours:
| Previous close | 5.29 |
| Open | 5.26 |
| Bid | 5.63 x 100 |
| Ask | 0.00 x 0 |
| Day's range | 5.26 - 5.92 |
| 52-week range | 2.85 - 15.00 |
| Volume | |
| Avg. volume | 137,098 |
| Market cap | 72.326M |
| Beta (5Y monthly) | -0.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2023, along with recent business updates.
- PR Newswire
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
Prenetics Global Limited (NASDAQ:PRE), a leading genomics-driven health sciences company, announces the signing of a Memorandum of Understanding (MOU), that paves the way for a strategic investment in Metavisionaries and a pioneering five-year research agreement with them and their partners Space Application Services through their Metaspace Venture. The parties will also establish a Space Innovation Lab within the UAE Space Agency. The inaugural Prenetics research cube is scheduled to on-board t
- PR Newswire
Prenetics Announces Third Quarter 2023 Financial Results
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the third quarter ended September 30, 2023, along with recent business updates.
